ODN 1826 control (ODN 2138) - TLR9 Ligand

Negative control for ODN 1826

ABOUT

Negative control for ODN 1826 - Class B CpG oligonucleotide - Mouse TLR9-preferred ligand

ODN 1826 Control (also known as ODN 2138) is designed as a negative control for the TLR9 agonist ODN 1826, an immunostimulatory Class B CpG oligonucleotide (ODN) with a preference for mouse Toll-like receptor 9 (TLR9). CpG ODNs are short synthetic single-stranded DNA molecules containing unmethylated CpG dinucleotides (CpG motifs). These unmethylated CpG motifs mimic microbial DNA and act as immunostimulants via TLR9. 

Mode of action

Stimulatory CpG ODNs are internalized and activate the endosomal receptor TLR9. Activation of TLR9 triggers NF-κB- and interferon regulatory factor (IRF)-mediated pro-inflammatory responses upon the recognition of unmethylated cytosine-phosphorothioate-guanosine (CpG) forms of DNA [1-3]. Unmethylated CpG dinucleotides are a hallmark of microbial (bacterial, viral, fungal, and parasite) DNA and mitochondrial self-DNA [3, 4].

CpG Class B ODNs, such as ODN 1826, are characterized by a fully phosphorothioate-modified backbone, nuclease resistant, and one or more unmethylated CpG motifs. 
InvivoGen's ODN 1826 Control contains GpC dinucleotides instead of CpGs and does not induce TLR9 activity [5-7].

In HEK-Blue™ mTLR9 reporter cells, ODN 1826 Control does not activate hTLR9 when compared to the immunostimulator ODN 1826.

Key features of ODN 1826 Control

  • Negative control of the human TLR9-activating ODN 1826
  • Synthetic ODN with unmethylated GpC motifs
  • Each lot is functionally tested

Get more information about CpG ODNs Classes.

1. Kumagai Y. et al., 2008. TLR9 as a key receptor of the recognition of DNA. Adv. Drug. Deliv. Rev. 60(7):795-804.
2. Heinz L.X. et al., 2021. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature. 581(7808):316-322.
3. Kayraklioglu N. et al., 2021. CpG oligonucleotides as vaccine adjuvants. DNA Vaccines: Methods and Protocols. Methods in Molecular Biology. Vol. 2197. p51-77.
4. Kumar V., 2021. The trinity of cGAS, TLR9, and ALRs: guardians of the cellular galaxy against host-derived self-DNA. Front. Immunol. 11:624597.
5. Krieg A.M. et al., 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374(6522):546-9.
6. Vollmer J. et al., 2004. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34: 251–62.
7. Rothenfusser S. et al., 2004. CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro. Blood 103:2162-9.

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Source
Synthetic
Synonyms
ODN 2138
Target

TLR9

Sequence

5’-tccatgagcttcctgagctt-3’ (20 mer) 

Note: Regular letters represent phosphorothioate bonds, bold letters represent GpC dinucleotides.

Molecular weight
6364 g/mol
Working concentration

1-5 μM for cellular assays

Solubility

5 mg/ml in water

Appearance (form)
Lyophilized
Reconstitution buffer
Sterile endotoxin-free water (provided)
Endotoxin

Negative (tested using EndotoxDetect™ assay)

Applications

Absence of TLR9 activity (tested) 

Quality control

Each lot is functionally tested and validated using HEK-Blue™ mTLR9 Cells.

CONTENTS

Contents

  • Product: 
    ODN 1826 control (ODN 2138)
  • Cat code: 
    tlrl-1826c-1
  • Quantity: 
    1 mg
Includes:

1 ml of sterile endotoxin-free water

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • Upon receipt, store product at -20 °C

    Caution:

    • Avoid repeated freeze-thaw cycles

DOCUMENTS

Documents

ODN 1826 control (ODN 2138)

Technical Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?